That is necessary, since the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and be effective. In other words, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (genetic sequencing companies jeff brown). However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. This was a development practically nobody observed. But it's going to have profound implications for treating disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be a lot of investment opportunities in this area, too. Moving subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown 2021 predictions). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it pulled back perhaps considerably before going greater - jeff brown prediction. I've been covering bitcoin for a long period of time now. Among the very first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were primarily educating readers. But that's not the huge question any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So think about that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. tech stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are so many terrific personal companies on the edge of striking the public markets And I've been dealing with a new method for you to invest even before these companies go public.
This opportunity has been developing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to reserve your area free of charge.
Emma Walsh here, handling editor of the Diary. Regular Diary readers know that tech isn't our normal beat (jeff brown genome sequencing). And when it concerns tech investing, we leave it to the experts. Fortunately, we have numerous such experts in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing professionals we know (jeff brown genome sequencing). In truth, he had a number of triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge photo and predict what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and far more. These trends are experiencing exponential growth and developing incredible opportunities for financiers. I desire to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown stock predictions 2021. However in spite of what lots of readers may think, this is a trend that's simply starting. Despite the fact that the COVID-19 pandemic interfered with supply chains last year, an impressive 250 million 5G-enabled devices were still sold.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (tech predictions). Losing 2 months of production and sales actually affects how numerous 5G gadgets are offered in the fiscal year. When you think about all of that, offering 250 million systems is amazing. More notably, the hold-ups triggered by the pandemic created a load of pent-up need. Which demand is now going to be pressed into 2021. In truth, I anticipate that more than 500 million 5G devices will be delivered in 2021 - jeff brown 2021 stock picks. Which's not my only 5G prediction When I've discussed 5G in the past, I've described its three various phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other products start to reach customers. And in Stage Three, 5G services begin to be offered (brownstone research stock). That's when we start to see applications operating on 5G networks. Think of things like enormous multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Stage 3 by this summertime. This starts something of a virtuous cycle: Many people do not really appreciate the innovation. But they will care if there are interesting applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In reality, 5G is going to open a suite of extraordinary applications: self-driving cars, the Internet of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment opportunities moving forward will be huge. Stepping far from 5G, the next essential technology I predict in 2021 is CRISPR genetic editing. CRISPR means "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software.
The program can crash or not function correctly. CRISPR utilizes a similar concept however with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can fix these "typos." For many years, CRISPR was mainly a niche innovation that wasn't well understood. And during that time, there were really only three companies running in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and delivering incredible returns. This entire industry is efficiently a greenfield opportunity.
There's space for many companies to exist in this area. jeff brown biotech pick. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or 3 more genetic modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing amazing things taking place at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software can precisely predict the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is necessary due to the fact that the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has actually been an experimental procedure. Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're designed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but numerous drug therapies produced utilizing this technology. This was one of those advancements that practically nobody observed. But it's going to have profound ramifications for curing disease. And, obviously, there will be a lot of financial investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it drew back maybe significantly before going greater. I've been covering bitcoin for a very long time now. One of the very first research study reports I ever released was on bitcoin - jeff brown 1 biotech company. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anyone who followed my recommendation. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. jeff bezos. Mass, Mutual is a 150-year-old organization. So think about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the information depends on date as of February 2021, but we might not independently confirm this claim. Given Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like capability to pick winning innovation stocks. He invested more than 25 years looking into technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an exceptional viewpoint on the market. He's constantly on the hunt for brand-new opportunities, and he shares a number of his finest choices in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an outstanding credibility as a stock-picker, and he effectively predicted some of the biggest economic events of the previous 20 years. Although he does not appear to launch his picks to the public, the service's success is a direct sign of Brown's stock-picking prowess. No one on Wall Street gets it best every time, however Jeff Brown's precise predictions have actually made him legions of devoted followers. That states a lot about his capability. The Near Future Report is published by Brownstone Research study, a popular monetary research study publisher. Brownstone Research study uses several research services with a large range of expertises - jeff brown genetic sequencer stock.
The business is also affiliated with Bonner & Partners, another well-respected research study publisher - jeff brown prediction for 2021. On its site, Brownstone says its mission is to supply retail investors with professional-grade research study: "For too long, the best financial investment research study has not been available to specific financiers. It has actually been typically reserved for financial investment banks, hedge funds, personal equity, and high-net-worth customers. black sea. The mission of Brownstone Research study is to make that type of proprietary research study offered to any investors looking to acquire an edge in the marketplaces. The goal is simple to deliver distinct and lucrative financial investment research study found no place else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also works as the firm's Chief Financial investment Analyst.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After years of steady success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout many of America. If you understand even a little bit about the market, you know that he has a track record as a King Midas of sorts. last year. Whatever he touches relies on gold! Jeff is well aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In truth, Brown believes S.A.V. social media. could be "the greatest trend of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be weding 2 innovative technologies: expert system and electric automobiles. Musk hopes the combination will help him develop the first fully-autonomous, self-driving automobiles ever. It's nothing brief of the vehicle market's Holy Grail. As you know, electric vehicles and self-driving vehicle stocks have actually been substantial this year, but the Wall Street device has actually approved hype without much concrete result. Regardless of a drastic boost in competitors over the previous few years, Brown still believes Musk has the very best opportunity of putting everything together.
tech could be the magic string that connects all of it together. S.A.V. means Shared Autonomous Automobile, and it might be the future of transport. Basically, this innovation would allow you to lease your car as a self-governing, self-driving taxi when you're not using it. You just leave the cars and truck and press a button on an app that tells the vehicle to "sign up with the fleet." Next thing you understand, you're relaxing on your couch while your car shuttles ride-sharers around town. Best of all, you get to keep a large chunk of the revenues. It sounds insane, but it could be closed than you believe.